These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Dwivedi Y; Rizavi HS; Pandey GN Neuroscience; 2006; 139(3):1017-29. PubMed ID: 16500030 [TBL] [Abstract][Full Text] [Related]
10. Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal Cortex. Yan L; Xu X; He Z; Wang S; Zhao L; Qiu J; Wang D; Gong Z; Qiu X; Huang H Biomed Res Int; 2020; 2020():2794263. PubMed ID: 32185198 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation. Musazzi L; Rimland JM; Ieraci A; Racagni G; Domenici E; Popoli M Int J Neuropsychopharmacol; 2014 May; 17(5):779-91. PubMed ID: 24451568 [TBL] [Abstract][Full Text] [Related]
12. Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells. Donnici L; Tiraboschi E; Tardito D; Musazzi L; Racagni G; Popoli M BMC Neurosci; 2008 Jul; 9():61. PubMed ID: 18601743 [TBL] [Abstract][Full Text] [Related]
13. Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus. Cooke JD; Cavender HM; Lima HK; Grover LM Psychopharmacology (Berl); 2014 Dec; 231(23):4429-41. PubMed ID: 24781518 [TBL] [Abstract][Full Text] [Related]
14. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects. Pilar-Cuéllar F; Vidal R; Pazos A Br J Pharmacol; 2012 Feb; 165(4b):1046-57. PubMed ID: 21627639 [TBL] [Abstract][Full Text] [Related]
15. Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment. Martínez-Turrillas R; Del Río J; Frechilla D Neuropharmacology; 2005 Dec; 49(8):1178-88. PubMed ID: 16143352 [TBL] [Abstract][Full Text] [Related]
16. Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses. Wyneken U; Sandoval M; Sandoval S; Jorquera F; González I; Vargas F; Falcon R; Monari M; Orrego F Neuropsychopharmacology; 2006 Nov; 31(11):2415-23. PubMed ID: 16554746 [TBL] [Abstract][Full Text] [Related]
17. Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats. Alboni S; Benatti C; Capone G; Corsini D; Caggia F; Tascedda F; Mendlewicz J; Brunello N Eur J Pharmacol; 2010 Sep; 643(2-3):180-7. PubMed ID: 20599917 [TBL] [Abstract][Full Text] [Related]
18. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Torregrossa MM; Folk JE; Rice KC; Watson SJ; Woods JH Psychopharmacology (Berl); 2005 Nov; 183(1):31-40. PubMed ID: 16220339 [TBL] [Abstract][Full Text] [Related]
19. Running exercise-induced up-regulation of hippocampal brain-derived neurotrophic factor is CREB-dependent. Chen MJ; Russo-Neustadt AA Hippocampus; 2009 Oct; 19(10):962-72. PubMed ID: 19294650 [TBL] [Abstract][Full Text] [Related]
20. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Russo-Neustadt A; Ha T; Ramirez R; Kesslak JP Behav Brain Res; 2001 Apr; 120(1):87-95. PubMed ID: 11173088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]